InnoCan Pharma Corporation (INNPF)
OTCMKTS · Delayed Price · Currency is USD
0.1471
0.00 (0.00%)
Jul 21, 2025, 4:00 PM EDT

InnoCan Pharma Company Description

InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

The company operates in two segments: Online Sales and Other Operations. It engages in the research and development of CBD loaded exosomes, as well as operates LPT CBD-loaded liposome platform that facilitates exact dosing and the prolonged and controlled release of CBD into the blood stream for epilepsy and pain management.

The company is involved in the development and sale of CBD-integrated pharmaceuticals and topical products.

In addition, it develops and markets a portfolio of self-care products for healthier lifestyle. The company was incorporated in 2018 and is headquartered in Calgary, Canada.

InnoCan Pharma Corporation
InnoCan Pharma logo
CountryCanada
Founded2018
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
CEOIris Bincovich

Contact Details

Address:
1015, 926 – 5 Avenue SW
Calgary, T2P 0N7
Canada
Phone403-777-1519
Websiteinnocanpharma.com

Stock Details

Ticker SymbolINNPF
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberCA45783P1027
SIC Code2833

Key Executives

NamePosition
Roni KamhiChief Operating Officer and Chief Executive Officer of BI Sky Global and Director
Iris BincovichChief Executive Officer and Director
Ron MayronExecutive Chairman
Nelson Harvey Halpern F.C.A., FCPAChief Financial Officer
Eyal Flom L.L.M., M.B.A.Director and Company Secretary
Yoram DruckerFounder and Executive Vice President of Business Development